Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer.

Sci Rep · 2021 · PMC8476586 · PMID 34580336

Europe PMC DOI

hedged sentence

0.1110

closest p · 2.2× alpha

0.1110

boldest claim

The sentences

did not reach statistical significancep = 0.111not close (p > 0.1)

There was a trend towards a correlation between PD-L1 expression and longer PFS, although it did not reach statistical significance per univariate Cox survival regression analysis (p = 0.111).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.